Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "Tinengotinib in Pts With Advanced, FGFR Inhibitor R/R Cholangiocarcinoma"

133 views
October 26, 2023
Comments 0
Login to view comments. Click here to Login